As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

U.S. restrictions on Chinese biotechnology could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict Chinese biotechnology, framing it as an extension of the tech war that would harm patien

European biotech leaders explore China's role in global life sciences innovation at Paris roundtable

A roundtable discussion in Paris examined China's evolving role in the global biotechnology ecosystem, focusing on how European life science

China's biotech rise: A case study in multiple myeloma drug development

This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc

The value of Chinese Biotech